IKZF1 and acute myeloid leukemia: These findings warrant the further evaluation of IKZF1 mutation status for clinical decision making as well as the development of therapeutic strategies to alleviate the dismal outcomes of IKZF1-mutated AML, for example, using combinatorial strategies including IMiDs.